Royal Bank of Canada’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500,000
Closed -$47.7M 7141
2025
Q4
$47.7M Buy
+500,000
New +$49M 0.01% 969
2021
Q2
Sell
-29,700
Closed -$1.15M 7484
2021
Q1
$1.15M Buy
29,700
+7,800
+36% +$295K ﹤0.01% 3450
2020
Q4
$787K Buy
+21,900
New +$789K ﹤0.01% 3721
2019
Q4
Sell
-1,530,000
Closed -$62.3M 6830
2019
Q3
$62.3M Buy
+1,530,000
New +$64.8M 0.02% 521
2019
Q2
Sell
-1,366,600
Closed -$52.5M 6875
2019
Q1
$52.5M Buy
1,366,600
+1,269,700
+1,310% +$48.5M 0.02% 554
2018
Q4
$3.42M Buy
+96,900
New +$3.51M ﹤0.01% 2268
2017
Q2
Sell
-46,300
Closed -$1.15M 6565
2017
Q1
$1.15M Buy
+46,300
New +$1.13M ﹤0.01% 2982

Other funds holding BSX

Royal Bank of Canada's BSX Position: Q1 2026 in Review

Royal Bank of Canada increased its Boston Scientific (BSX) stake by 13% in Q1 2026, buying an estimated $57.7M and bringing the position to 6,273,263 shares worth $394M. The position accounts for 0.07% of the portfolio, ranked #257.

Royal Bank of Canada first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $753M in Q3 2025. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Royal Bank of Canada held 6,273,263 shares of Boston Scientific worth $394M as of Q1 2026.
  • Royal Bank of Canada bought 721,691 Boston Scientific shares in Q1 2026, an estimated $57.7M.
  • Boston Scientific made up 0.07% of Royal Bank of Canada's portfolio in Q1 2026, its #257 holding.
  • Royal Bank of Canada first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Boston Scientific position peaked at $753M in Q3 2025.
  • 1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.